Speaker / 주요 연사

이병철 대표, Ph.D / KANAPH Therapeutics

강연 제목 :
Key note: Lessons from the past ADC development and the future

  • 現 CEO, KANAPH Therapeutics
  • 現 국가신약개발재단 (Korea Drug Development Fund), ADCaptain 프로젝트 자문위원
  • Santen, Director, New biologics research
  • 23andMe, Head of analytics and project lead
  • Genentech, Research scientist, ADC linker-payload and next generation HER2 ADC development
  • Lawrence Berkeley National Laboratory, Post-doctoral fellow
  • University of California San Francisco (UCSF), Ph.D.

박윤희 박사 / LegoChem Biosciences

강연 제목 :
ADC development and bioanalysis: How to manage issues in development

  • 2011-Present : Principal Research Scientist/ Project leader/ LegoChem Biosciences, Inc.
  • Research interest
    • Development of various ADCs (Antibody drug conjugates)
    • Screening of small molecule anti-cancer drug
    • Functional study of the dual specificity kinase (LAMMER kinase) in regulation of fission yeast cell cycle
  • 2019  중소벤처기업부 장관 표창

Reitsma, Dirk / Senior Vice President, Med Science, and Strategy

강연 제목 :
Latest trends in precision medicine in pharma clinical trials and use of next-generation sequencing

  • Senior vice president and global therapeutic area head of hematology and oncology for the PPD clinical research business of Thermo Fisher Scientific
  • Extensive experience in the application of adaptive and other Bayesian clinical trial methods, as well as with complex and innovative trial designs.
  • Major contributor to the methodology of biosimilar trial design, adaptive trial design, basket, and platform trial capabilities, digitization of trials, and expanded application of synthetic and external controls to clinical development.
  • Over 20 years of experience in oncology clinical development in both large pharma and biotech and has worked on four oncology drug approvals in multiple tumor types.

Li, Jane / Senior Director, Global Companion Diagnostics, Genetic Sciences

강연 제목 :
Latest trends in precision medicine in pharma clinical trials and use of next-generation sequencing

  • Senior Director, Global Companion Diagnostics for Thermo Fisher Scientific’s Clinical Sequencing since 2015.
  • Senior Director, Clinical and Pharma Services for the Clinical Sequencing
  • Over 20 years of experience in corporate strategy, business development, and M&A at Thermo Fisher Scientific

Agnew, Brian J. / Senior Staff Scientist,Global OEM and Licensing

강연 제목 :
Bioconjugation labeling tools and services for site-specific chemoenzymatic antibody conjugation

  • Senior Staff Scientist at Thermo Fisher Scientific for 10 years developing various methods for the labeling and detection of proteins and nucleic acids
  • Project leader of SiteClick™ development (SiteClick™ : Site-specific antibody conjugation technology for the attachment of various different payloads to antibodies, including toxins for ADC development, amongst others.)
  • Part of global OEM and licensing to OEM customers who are applying our technologies to their specialized platforms